Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer

NCT02899078 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Cancer
Stage IV Renal Cell Cancer

Interventions

DRUG: Ibrutinib
DRUG: Nivolumab

Sponsor

University of California, Davis

Collaborators

[object Object]